Here are some lessons we learned during a recent interview with CFO Alan Ol...

With a strong focus on the collaboration needed to solve problems common to...

Using the pioneering Kymouse human antibody expression platform, Kymab are ...

In March of this year, an article published in Science made waves throughou...

Equity crowdfunding is particulary suited to life sciences

What is equity crowdfunding? To any average member of Joe public, the word ...

Having recently listed on the London Stock Exchange, CEO Doug Doerfler tell...

Christian Girard, expert in orphan drugs, competitive intelligence, in/out ...

Biotech and Money had the opportunity to speak with Alastair Smith, the CEO...

Biotech companies have fared well recently in the IPO market in both the US...

Ian has over 25 years of international experience in management and transac...

Comprising a team with expertise in both development and commercialisation,...